Page 63 - Read Online

Galicia-Moreno et al. Hepatoma Res 2020;6:20 I http://dx.doi.org/10.20517/2394-5079.2019.36 Page 17 of 18

dependent amplification and gold nanoparticle probes. Diagn Microbiol Infect Dis 2008;62:119-24.
62. Carter JR, Balaram V, Kucharski CA, Fraser TS, Fraser MJ. A novel dengue virus detection method that couples DNAzyme and gold
nanoparticle approaches. Virol J 2013;10:201.
63. Liu Y, Zhang L, Wei W, Zhao H, Zhou Z, et al. Colorimetric detection in influenza a virus using antibody-functionalized gold
nanoparticles. Analyst 2015;140:3989-95.
64. Wang C, Zhang L, Shen X. Development of a nucleic acid lateral flow strip for detection of hepatitis C virus (HCV) core antigen.
Nucleosides Nucleotides Nucl Acids 2013;32:59-68.
65. Daniele B, Bencivenga A, Megna AS, Tinessa V. a-fetoprotein and ultrasonography screening for hepatocellular carcinoma.
Gastroenterology 2004;127:S108-12.
66. Fassio E, Mazzolini G, AAEEH. Consenso y guías Argentinas para la vigilancia, Diagnóstico y Tratamiento del Hepatocarcinoma.
Acta Gastroenterol Latinoam 2016;46:350-74. (in Spanish)
67. Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999;19:329-38.
68. Meza-Junco J, Montaño-Loza A, Myrna C. Treatment modalities in patients with hepatocellular carcinoma: a restrospective series in a
single institution in Mexico. Gastroenterol Hepatol 2004;27:11-7.
69. Grazi GL, Ercolani G, Pierangeli F, Del Gaudio M, Cescon M, et al. Improved results of liver resection for hepatocellular carcinoma
on cirrhosis give the procedure added value. Ann Surg 2001;234:71-8.
70. Poon RT, Fan ST, Ng IO, Wong J. Significance of resection marging in hepatectomy for hepatocellular carcinoma: a critical
reappraisal. Ann Surg 2000;23:544-51.
71. Imamura H, Matsuyama Y, Miyagawa Y, Ishida K, Shimada R, et al. Prognostic significance of anatomical resection and des-gamma-
carboxy prothrombin in patients with hepatocellular carcinoma. Br J Surg 1999;86:1032-38.
72. Hasegawa K, Kokudo N, Imamura H, Matsuyama Y, Aoki T, et al. Prognostic impact of anatomic resection for hepatocellular
carcinoma. Ann Surg 2005;242:252-9.
73. Kosuge T, Makuuchi M, Takayama T, Yamamoto J, Shimada K, et al. Long-term results after resection of hepatocellular carcinoma:
experience of 480 cases. Hepatogastroenterology 1993;40:328-32.
74. Carrilho FJ, Kikuchi L, Branco F, Sandoval Goncalves C, Aves de Mattos A, et al. Clinical and epidemiological aspects of
hepatocellular carcinoma in Brazil. Clinics 2010;65:1285-90.
75. Fan ST. Hepatocellular carcinoma- resection or transplant? Nat Rev Gastroenterol Hepatol 2012;9:732-37.
76. Clavien PA, Lesurtel M, Bossuyt PM, Gores GJ, Langer B, et al. Recommendations for liver transplantation for hepatocellular
carcinoma: an international consensus coference report. Lacet Oncol 2012;13:e11-22.
77. Mazzaferro V, Bhoori S, Sposito C, Bongini M, Langer M, et al. Milan criteria in liver transplantation for hepatocellular carcinoma: an
evidence-based analysis of 15 years of experience. Liver Transpl 2011;17:S44-57.
78. Sociedad de Trasplantes de América Latina y el Caribe (Stalyc). Newsletter transplant international figures on donation and
transplantation 2016. Available from: https://stalyc.net/utilidades/biblioteca/publicaciones/file/94-newsletter-transplant-22.html [Last
accessed on 16 Apr 2020]
79. Sociedad de Trasplantes de América Latina y el Caribe (Stalyc). Latin America Transplantation Registry Report 2015-2016. Available
from: https://www.stalyc.net/registros/file/74-latin-america-transplantation-registry-report-2015-2016.html [Last accessed on 16 Apr
2020]
80. Inchingolo R, Posa A, Mariappan M, Spiliopoulos S. Locoregional treatments for hepatocellular carcinoma: current evidence and
future directions. World J Gastroenterol 2019;28:4614-28.
81. N’Kontchou G, Mahamoudi A, Aout M, Ganne-Carrié N, Grando V, et al. Radiofrequency ablation of hepatocellular carcinoma: long-
term results and prognostic factors in 235 Western patients with cirrhosis. Hepatology 2009;50:1475-83.
82. Lu DS, Yu NC, Raman SS, Limanond P, Lassman C, et al. Radiofrequency ablation of hepatocellular carcinoma: treatment success as
defined by histologic examination of the explanted liver. Radiology 2005;234:954-60.
83. Sato S, Shiratori Y, Imamura M, Teratani T, Obi S, et al. Power Doopler signals after percutaneous ethanol injection therapy
for hepatocellular carcinoma predict local recurrence of tumors: a prospective study using 199 consecutive patients. J Hepatol
2001;35:225-34.
84. Lencioni R, Crocetti L. Local-regional treatment of hepatocellular carcinoma. Radiology 2012;262:43-58.
85. Khan KN, Yatsuhashi H, Yamasaki K, Yamasaki M, Inoue O, et al. Prospective analysis of risk factors for early intrahepatic recurrence
of hepatocellular carcinoma following ethanol injection. J Hepatol 2000;32:269-78.
86. Dou JP, Liang P, Yu J. Microwave ablation for liver tumors. Abdom Radiol 2016;41:650-8.
87. Glassberg MB, Ghosh S, Clymer JW, Wright GWJ, Ferko N, et al. Microwave ablation compared with hepatic resection for the
treatmemt of hepatocellular carcinoma and liver metastases: a systematic review and meta-analysis. World J Surg Oncol 2019;17:98.
88. Doo Song K. Percutaneous cryoablation for hepatocellular carcinoma. Clin Mol Hepatol 2016;22:509-15.
89. Zimmerman A, Grand D, Charpentier KP. Irreversible electroporation of hepatocellular carcinoma: patient selection and perspectives.
J Hepatocell Carcinoma 2017;13:49-58.
90. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves
survival. Hepatology 2003;37:429-42.
91. Bouvry C, Palard X, Edeline J, Ardisson V, Loyer P, et al. Transarterial radioembolization (TARE) agents beyond 90Y microspheres.
Biomed Res International 2018;2018:1-14.
92. Hsieh TC, Wu YC, Sun SS, Yen KY, Kao CH. Treating hepatocellular carcinoma with 90Y-bearing microspheres: a review.
Biomedicine 2016;6:19.
93. Bruix J, Sherman M; American Association for the Study of the Liver Diseases. Management of hepatocellular carcinoma: an up date.
Hepatology 2011;53:1020-2.